272 related articles for article (PubMed ID: 9572918)
1. Solid state characterization of spray-dried powders of recombinant human deoxyribonuclease (rhDNase).
Chan HK; Gonda I
J Pharm Sci; 1998 May; 87(5):647-54. PubMed ID: 9572918
[TBL] [Abstract][Full Text] [Related]
2. Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.
Akdag Cayli Y; Sahin S; Buttini F; Balducci AG; Montanari S; Vural I; Oner L
Drug Dev Ind Pharm; 2017 Aug; 43(8):1378-1389. PubMed ID: 28420285
[TBL] [Abstract][Full Text] [Related]
3. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
[TBL] [Abstract][Full Text] [Related]
4. Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery.
Chan HK; Clark A; Gonda I; Mumenthaler M; Hsu C
Pharm Res; 1997 Apr; 14(4):431-7. PubMed ID: 9144727
[TBL] [Abstract][Full Text] [Related]
5. Formulation and process development of (recombinant human) deoxyribonuclease I as a powder for inhalation.
Zijlstra GS; Ponsioen BJ; Hummel SA; Sanders N; Hinrichs WL; de Boer AH; Frijlink HW
Pharm Dev Technol; 2009; 14(4):358-68. PubMed ID: 19552563
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
Simon A; Amaro MI; Cabral LM; Healy AM; de Sousa VP
Int J Pharm; 2016 Mar; 501(1-2):124-38. PubMed ID: 26836711
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery.
Li X; Mansour HM
AAPS PharmSciTech; 2011 Dec; 12(4):1420-30. PubMed ID: 22038473
[TBL] [Abstract][Full Text] [Related]
9. Generation of fine powders of recombinant human deoxyribonuclease using the aerosol solvent extraction system.
Bustami RT; Chan HK; Sweeney T; Dehghani F; Foster NR
Pharm Res; 2003 Dec; 20(12):2028-35. PubMed ID: 14725370
[TBL] [Abstract][Full Text] [Related]
10. Determination of low levels of amorphous content in inhalation grade lactose by moisture sorption isotherms.
Vollenbroek J; Hebbink GA; Ziffels S; Steckel H
Int J Pharm; 2010 Aug; 395(1-2):62-70. PubMed ID: 20493937
[TBL] [Abstract][Full Text] [Related]
11. The characterization and comparison of spray-dried mannitol samples.
Hulse WL; Forbes RT; Bonner MC; Getrost M
Drug Dev Ind Pharm; 2009 Jun; 35(6):712-8. PubMed ID: 19514986
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
13. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
Lu W; Rades T; Rantanen J; Yang M
Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
[TBL] [Abstract][Full Text] [Related]
14. Development and Characterization of Dapsone Cocrystal Prepared by Scalable Production Methods.
do Amaral LH; do Carmo FA; Amaro MI; de Sousa VP; da Silva LCRP; de Almeida GS; Rodrigues CR; Healy AM; Cabral LM
AAPS PharmSciTech; 2018 Aug; 19(6):2687-2699. PubMed ID: 29968042
[TBL] [Abstract][Full Text] [Related]
15. Physical stability of salmon calcitonin spray-dried powders for inhalation.
Chan HK; Clark AR; Feeley JC; Kuo MC; Lehrman SR; Pikal-Cleland K; Miller DP; Vehring R; Lechuga-Ballesteros D
J Pharm Sci; 2004 Mar; 93(3):792-804. PubMed ID: 14762916
[TBL] [Abstract][Full Text] [Related]
16. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
[TBL] [Abstract][Full Text] [Related]
17. Preparation and Characterization of Inhalable Ivermectin Powders as a Potential COVID-19 Therapy.
Albariqi AH; Ke WR; Khanal D; Kalfas S; Tang P; Britton WJ; Drago J; Chan HK
J Aerosol Med Pulm Drug Deliv; 2022 Oct; 35(5):239-251. PubMed ID: 35275749
[No Abstract] [Full Text] [Related]
18. Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders.
Maa YF; Nguyen PA; Andya JD; Dasovich N; Sweeney TD; Shire SJ; Hsu CC
Pharm Res; 1998 May; 15(5):768-75. PubMed ID: 9619788
[TBL] [Abstract][Full Text] [Related]
19. Effects of hydrolysis on solid-state relaxation and stickiness behavior of sodium caseinate-lactose powders.
Mounsey JS; Hogan SA; Murray BA; O'Callaghan DJ
J Dairy Sci; 2012 May; 95(5):2270-81. PubMed ID: 22541456
[TBL] [Abstract][Full Text] [Related]
20. Amino acids as stabilizers for spray-dried simvastatin powder for inhalation.
Lu W; Rades T; Rantanen J; Chan HK; Yang M
Int J Pharm; 2019 Dec; 572():118724. PubMed ID: 31678523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
